Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marina E. Sánchez‐Frias"'
Autor:
Juan L. López‐Cánovas, Natalia Hermán‐Sánchez, Maria Trinidad Moreno‐Montilla, Mercedes del Rio‐Moreno, Emilia Alors‐Perez, Marina E. Sánchez‐Frias, Víctor Amado, Rubén Ciria, Javier Briceño, Manuel de laMata, Justo P. Castaño, Manuel Rodriguez‐Perálvarez, Raúl M. Luque, Manuel D. Gahete
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 11, Pp n/a-n/a (2022)
Abstract Introduction Altered splicing landscape is an emerging cancer hallmark; however, the dysregulation and implication of the cellular machinery controlling this process (spliceosome components and splicing factors) in hepatocellular carcinoma (
Externí odkaz:
https://doaj.org/article/44c65a5a43f5401cba4cff96e19ce370
Autor:
Juan L. López-Cánovas, Natalia Hermán-Sánchez, Mercedes del Rio-Moreno, Antonio C. Fuentes-Fayos, Araceli Lara-López, Marina E. Sánchez-Frias, Víctor Amado, Rubén Ciria, Javier Briceño, Manuel de la Mata, Justo P. Castaño, Manuel Rodriguez-Perálvarez, Raúl M. Luque, Manuel D. Gahete
Publikováno v:
Experimental & Molecular Medicine. 55:132-142
Hepatocellular carcinoma (HCC) pathogenesis is associated with alterations in splicing machinery components (spliceosome and splicing factors) and aberrant expression of oncogenic splice variants. We aimed to analyze the expression and potential role
Autor:
Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, María Trinidad Moreno‐Montilla, Víctor García‐Vioque, Juan Manuel Jiménez‐Vacas, Andrea Mafficini, Iranzu González‐Borja, Claudio Luchini, Juan M. Sánchez‐Hidalgo, Marina E. Sánchez‐Frías, Sergio Pedraza‐Arevalo, Antonio Romero‐Ruiz, Rita T. Lawlor, Antonio Viúdez, Manuel D. Gahete, Aldo Scarpa, Álvaro Arjona‐Sánchez, Raúl M. Luque, Alejandro Ibáñez‐Costa, Justo P. Castaño
Publikováno v:
Molecular Oncology, Vol 18, Iss 10, Pp 2524-2540 (2024)
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer, characterized by late diagnosis and poor treatment response. Surgery is the only curative approach, only available to early‐diagnosed patients. Current therapies have limited effect
Externí odkaz:
https://doaj.org/article/de947d6fca6d49f9911a2528b10949ca
Autor:
Juan L, López-Cánovas, Natalia, Hermán-Sánchez, Mercedes, Del Rio-Moreno, Antonio C, Fuentes-Fayos, Araceli, Lara-López, Marina E, Sánchez-Frias, Víctor, Amado, Rubén, Ciria, Javier, Briceño, Manuel, de la Mata, Justo P, Castaño, Manuel, Rodriguez-Perálvarez, Raúl M, Luque, Manuel D, Gahete
Publikováno v:
Experimentalmolecular medicine.
Hepatocellular carcinoma (HCC) pathogenesis is associated with alterations in splicing machinery components (spliceosome and splicing factors) and aberrant expression of oncogenic splice variants. We aimed to analyze the expression and potential role
Autor:
Emilia Alors-Pérez, Sergio Pedraza-Arevalo, Ricardo Blázquez-Encinas, Víctor García-Vioque, Antonio Agraz-Doblas, Elena M. Yubero-Serrano, Marina E. Sánchez-Frías, Raquel Serrano-Blanch, María Ángeles Gálvez-Moreno, Francisco Gracia-Navarro, Manuel D. Gahete, Álvaro Arjona-Sánchez, Raúl M. Luque, Alejandro Ibáñez-Costa, Justo P. Castaño
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 35, Iss 1, Pp 102090- (2024)
Pancreatic neuroendocrine tumors (PanNETs) comprise a heterogeneous group of tumors with growing incidence. Recent molecular analyses provided a precise picture of their genomic and epigenomic landscape. Splicing dysregulation is increasingly regarde
Externí odkaz:
https://doaj.org/article/46b3eb5e3ec743c68155cde95dd29e80
Autor:
Emilia Alors-Perez, Ricardo Blázquez-Encinas, Sonia Alcalá, Cristina Viyuela-García, Sergio Pedraza-Arevalo, Vicente Herrero-Aguayo, Juan M. Jiménez-Vacas, Andrea Mafficini, Marina E. Sánchez-Frías, María T. Cano, Fernando Abollo-Jiménez, Juan A. Marín-Sanz, Pablo Cabezas-Sainz, Rita T. Lawlor, Claudio Luchini, Laura Sánchez, Juan M. Sánchez-Hidalgo, Sebastián Ventura, Laura Martin-Hijano, Manuel D. Gahete, Aldo Scarpa, Álvaro Arjona-Sánchez, Alejandro Ibáñez-Costa, Bruno Sainz, Raúl M. Luque, Justo P. Castaño
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-21 (2021)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer, requiring novel treatments to target both cancer cells and cancer stem cells (CSCs). Altered splicing is emerging as both a novel cancer hallmark and an attractive
Externí odkaz:
https://doaj.org/article/2e57a0d7fd7f42d6a9f88e1c0cae6aca
Autor:
Iranzu González-Borja, Emilia Alors-Pérez, Irene Amat, Laura Alonso, Cristina Viyuela-García, Saioa Goñi, José C. Reyes, María Ceballos-Chávez, Irene Hernández-García, Marina E. Sánchez-Frías, Enrique Santamaría, Socorro Razquin, Álvaro Arjona-Sánchez, Virginia Arrazubi, Jairo Pérez-Sanz, Ruth Vera, Joaquín Fernández-Irigoyen, Justo P. Castaño, Antonio Viúdez
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Checkpoint with forkhead-associated and ring finger domains (CHFR) has been proposed as a predictive and prognosis biomarker for different tumor types, but its role in pancreatic ductal adenocarcinoma (PDAC) remains unknown. The aim of this study was
Externí odkaz:
https://doaj.org/article/aa8a20b687714e7c89f5590df6b0bb4f